Brekelmans, C.T.

cancer breast breast cancer women mutation patient family study brca 1 group screening carrier tumor prophylactic mastectomy table prophylactic mastectomy 1/2 brca 2 mutation survival mammography result diagnosis family history history percent number breast cancer patients breast cancer cases difference characteristic status netherland signi chemotherapy signi ficantly surveillance follow-up surgery interval department sensitivity visit oncol 2-associated breast cancers analysis cohort metastatic disease seynaeve c non-brca examination treatment imaging incidence stage university adjuvant therapy rotterdam model colorectal cancer contralateral fi rst-line chemotherapy breast cancer res brca 2 mutations carcinoma 1-associated ficantly erasmu brca 1- 0/0 metastatic breast cancer brekelman clinic breast examination complication colorectal index